2026. In Silico ADME–Toxicity Profiling of 3,4-dithia-1-azabicyclo[3.2.0]heptan-7-one: Integrating Drug-Likeness, Pharmacokinetics, and Prediction Confidence. Journal of Medical and Health Sciences (JMHS). 5, 1 (Sep. 2026), 61–80. DOI:https://doi.org/10.51317/jmhs.v5i1.1194.